Guardant Health 第二季度业绩强劲,股价飙升,上调 2025 年展望

英为财情
Jul 31, 2025

Investing.com -- Guardant Health Inc (NASDAQ:GH) 股价在该癌症检测公司报告好于预期的第二季度业绩并上调全年指引后飙升 5.7%,这一增长得益于所有业务部门的强劲表现。 这家精准肿瘤学公司公布第二季度调整后每股亏损为 -$0.44,明显优于分析师预期的每股亏损 -$0.72。收入同比增长 31% 至 2.321 亿美元,轻松超过 2.1127 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10